LAES · SEALSQ Corp
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-08 | Enguent Jean-Pierre |
Vice President, R&DSS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.73to $2.91, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
15,000 |
| 2026-07-06 | Enguent Jean-Pierre |
Vice President, R&DSS |
Convert↑
|
Ordinary Shares
|
15,000 |
| 2026-07-06 | Enguent Jean-Pierre |
Vice President, R&DSS |
Convert↓
Filing footnotes — Employee Stock Option Plan (right to buy) (Direct)
The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. |
Employee Stock Option Plan (right to buy)
|
15,000 |
| 2026-06-16 | Ward Peter |
Director |
Convert↓
Filing footnotes — Employee Stock Option Plan (right to buy) (Direct)
The accompanying tax-offset right, which was granted in tandem with the option, entitles the reporting person to receive, upon exercise of the option, a cash payment equal to the tax withholding incurred in connection with the exercise, including tax withholding incurred on the tax-offset payment. |
Employee Stock Option Plan (right to buy)
|
353,097 |
| 2026-06-16 | Ward Peter |
Director |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
The value of the withheld shares was calculated using a fair market value of $3.07 per share - the closing share price on June 16, 2026. |
Ordinary Shares
|
96,530 |
| 2026-06-16 | Ward Peter |
Director |
Convert↓
Filing footnotes — Employee Stock Option Plan (right to buy) (Direct)
The accompanying tax-offset right, which was granted in tandem with the option, entitles the reporting person to receive, upon exercise of the option, a cash payment equal to the tax withholding incurred in connection with the exercise, including tax withholding incurred on the tax-offset payment. |
Employee Stock Option Plan (right to buy)
|
13,649 |
| 2026-06-16 | Ward Peter |
Director |
Convert↑
|
Ordinary Shares
|
366,746 |
| 2026-06-05 | Moreira Carlos |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 12, 2025. |
Ordinary Shares
|
300 |
| 2026-06-05 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.54, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
143 |
| 2026-06-03 | Enguent Jean-Pierre |
Vice President, R&DSS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.44 to $3.66, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
15,000 |
| 2026-06-03 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.66, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
Ordinary Shares
|
5,582 |
| 2026-06-03 | Moreira Carlos |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.61, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
Ordinary Shares
|
7,005 |
| 2026-06-02 | Moreira Carlos |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.78, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-06-02 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.78, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-06-01 | Enguent Jean-Pierre |
Vice President, R&DSS |
Convert↑
|
Ordinary Shares
|
15,000 |
| 2026-06-01 | Enguent Jean-Pierre |
Vice President, R&DSS |
Award↑
|
Employee Stock Option Plan (right to buy)
|
60,000 |
| 2026-06-01 | Enguent Jean-Pierre |
Vice President, R&DSS |
Convert↓
Filing footnotes — Employee Stock Option Plan (right to buy) (Direct)
The options exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. |
Employee Stock Option Plan (right to buy)
|
15,000 |
| 2026-05-29 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.5 to $3.53, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-05-29 | Moreira Carlos |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.66, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-05-27 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.51, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
4,689 |
| 2026-05-27 | Moreira Carlos |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.515, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
4,139 |
| 2026-05-14 | Buonanno Franck Jean |
Vice-President, Global Sales |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. |
Ordinary Shares
|
20,000 |
| 2026-05-11 | Buonanno Franck Jean |
Vice-President, Global Sales |
Convert↑
|
Ordinary Shares
|
20,000 |
| 2026-05-11 | Buonanno Franck Jean |
Vice-President, Global Sales |
Convert↓
Filing footnotes — Employee Stock Option Plan (right to buy) (Direct)
The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. |
Employee Stock Option Plan (right to buy)
|
20,000 |
| 2026-05-06 | Enguent Jean-Pierre |
Vice President, R&DSS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.33, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
15,000 |
| 2026-05-04 | Enguent Jean-Pierre |
Vice President, R&DSS |
Convert↑
|
Ordinary Shares
|
15,000 |
| 2026-05-04 | Enguent Jean-Pierre |
Vice President, R&DSS |
Convert↓
Filing footnotes — Employee Stock Option Plan (right to buy) (Direct)
The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. |
Employee Stock Option Plan (right to buy)
|
15,000 |
| 2026-04-24 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.8234 to $2.97, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. |
Ordinary Shares
|
5,250 |
| 2026-04-23 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.7884 to $3.02, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-22 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.97 to $3.16, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-21 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.22, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-20 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.95, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-17 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.6471 to $2.85, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-16 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.60 to $2.7779, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-13 | O'Hara John Charles |
Director, Chief Financial Officer |
Award↑
|
Employee Stock Option (right to buy)
|
130,500 |
| 2026-04-13 | O'Hara John Charles |
Director, Chief Financial Officer |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. |
Employee Stock Option (right to buy)
|
130,500 |
| 2026-04-13 | O'Hara John Charles |
Director, Chief Financial Officer |
Convert↑
|
Ordinary Shares
|
130,500 |
| 2026-04-09 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.12, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-08 | Enguent Jean-Pierre |
Vice President, R&DSS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The option exercise and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.13 to $2.42, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
15,000 |
| 2026-04-08 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.13 to $2.41, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-07 | Feuardent Moreira Andreas |
Chief Innovation Officer |
Convert↑
|
Ordinary Shares
(I)
|
10,000 |
| 2026-04-07 | Feuardent Moreira Andreas |
Chief Innovation Officer |
Convert↓
Filing footnotes — Employee Stock Option Plan (right to buy) (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's wife on December 8, 2025. |
Employee Stock Option Plan (right to buy)
(I)
|
10,000 |
| 2026-04-07 | Feuardent Moreira Andreas |
Chief Innovation Officer |
Sell↓
|
Ordinary Shares
(I)
|
10,000 |
| 2026-04-07 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.11 to $2.31, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-06 | Enguent Jean-Pierre |
Vice President, R&DSS |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
The option exercise and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. |
Ordinary Shares
|
15,000 |
| 2026-04-06 | Enguent Jean-Pierre |
Vice President, R&DSS |
Convert↓
Filing footnotes — Employee Stock Option Plan (right to buy) (Direct)
The option exercise and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. |
Employee Stock Option Plan (right to buy)
|
15,000 |
| 2026-04-06 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.3625 to $2.52, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-04-02 | O'Hara John Charles |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.33 to $2.51, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Ordinary Shares
|
10,000 |
| 2026-03-31 | Buonanno Franck Jean |
Vice-President, Global Sales |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. |
Ordinary Shares
|
10,000 |
| 2026-03-30 | O'Hara John Charles |
Director, Chief Financial Officer |
Convert↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The options exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025. |
Employee Stock Option (right to buy)
|
100,000 |